Paediatric Oncology Literature

Thursday, 21 February 2013

1 vs 2 delayed intensifications for ALL 


Vora A, Goulden N, Wade R, Mitchell C, Hancock J, Hough R, Rowntree C,Richards S. Treatment reduction for children and young adults with low-risk acutelymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): arandomised controlled trial. Lancet Oncol. 2013 Feb 7. doi:pii:S1470-2045(12)70600-9. 10.1016/S1470-2045(12)70600-9.
Posted by Ramandeep Arora at 17:43 No comments:
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Labels: Chemotherapy, Leukaemia, mortality, MRD, Randomised Controlled Trial, UK
Newer Posts Older Posts Home
Subscribe to: Posts (Atom)

Labels

abandonment (3) Bone tumours (3) central america (1) Chemotherapy (3) Clinical Trial (1) CNS Tumours (4) COG (3) delayed diagnosis (2) England (5) Epidemiology (10) Febrile Neutropenia (2) GCT (1) Genetics (1) Guidelines (5) Histiocytosis (1) Hodgkin Disease (2) Incidence (6) India (12) Leukaemia (5) Medulloblastoma (1) mortality (3) MRD (2) Non-Hodgkin's Lymphoma (1) PHO IAP (1) PODC (2) Radiology (1) Radiotherapy (3) Raman (3) Randomised Controlled Trial (5) relapse (1) Report (2) retinoblastoma (1) Review (1) SIOP (3) soft tissue sarcoma (1) south america (1) Supportive Care (2) Trends (1) TYA (3) UK (1) Wilms Tumour (1)

Blog Archive

  • ▼  2013 (4)
    • ►  April (2)
    • ▼  February (1)
      • 1 vs 2 delayed intensifications for ALL
    • ►  January (1)
  • ►  2012 (26)
    • ►  December (1)
    • ►  November (2)
    • ►  October (3)
    • ►  September (20)

About Me

My photo
Ramandeep Arora
I have done my initial paediatric training in India and then went to UK for further training in paediatric oncology and cancer epidemiology. Having spent 11 years there I moved back to India in 2013 and have joined Max Healthcare, New Delhi as a consultant paediatric oncologist. My main area of interest is childhood cancer with a specific focus on paediatric oncology in developing countries and childhood cancer epidemiology. I am also interested in understanding the phenomenon of refusal and abandonment in treatment of childhood cancer in developing countries and to develop interventions to deal with it.
View my complete profile
Simple theme. Powered by Blogger.